BR112015031878A2 - composição farmacêutica - Google Patents
composição farmacêuticaInfo
- Publication number
- BR112015031878A2 BR112015031878A2 BR112015031878A BR112015031878A BR112015031878A2 BR 112015031878 A2 BR112015031878 A2 BR 112015031878A2 BR 112015031878 A BR112015031878 A BR 112015031878A BR 112015031878 A BR112015031878 A BR 112015031878A BR 112015031878 A2 BR112015031878 A2 BR 112015031878A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- formula
- compounds
- present
- pharmaceutically acceptable
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000003524 antilipemic agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2470MU2013 IN2013MU02470A (enExample) | 2013-07-25 | 2013-07-25 | |
| PCT/IN2014/000489 WO2015011730A1 (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015031878A2 true BR112015031878A2 (pt) | 2017-07-25 |
Family
ID=51787141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015031878A BR112015031878A2 (pt) | 2013-07-25 | 2014-07-24 | composição farmacêutica |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9610277B2 (enExample) |
| EP (1) | EP3024446A1 (enExample) |
| JP (1) | JP2016523895A (enExample) |
| KR (1) | KR101786843B1 (enExample) |
| CN (1) | CN105407873A (enExample) |
| AP (1) | AP2015008876A0 (enExample) |
| AR (1) | AR097067A1 (enExample) |
| AU (1) | AU2014294548B2 (enExample) |
| BR (1) | BR112015031878A2 (enExample) |
| CA (1) | CA2917923A1 (enExample) |
| EA (1) | EA201690072A1 (enExample) |
| HK (1) | HK1219222A1 (enExample) |
| IN (1) | IN2013MU02470A (enExample) |
| MA (1) | MA38865A1 (enExample) |
| MX (1) | MX374628B (enExample) |
| NZ (1) | NZ714558A (enExample) |
| PH (1) | PH12015502802A1 (enExample) |
| SG (1) | SG11201509798PA (enExample) |
| TW (1) | TW201545773A (enExample) |
| WO (1) | WO2015011730A1 (enExample) |
| ZA (1) | ZA201508682B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8149178B2 (en) | 2006-05-23 | 2012-04-03 | Intel Corporation | Millimeter-wave communication system with directional antenna and one or more millimeter-wave reflectors |
| PL2670486T3 (pl) | 2011-01-31 | 2016-08-31 | Cadila Healthcare Ltd | Leczenie lipodystrofii |
| GEP201706663B (en) | 2013-04-22 | 2017-05-10 | Cadila Healthcare Ltd | Novel composition for nonalcoholic fatty liver disease (nafld |
| EP3004053B1 (en) | 2013-05-30 | 2021-03-24 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201636015A (zh) | 2013-07-05 | 2016-10-16 | 卡地拉保健有限公司 | 協同性組成物 |
| IN2013MU02470A (enExample) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| WO2015033357A2 (en) | 2013-09-06 | 2015-03-12 | Cadila Healthcare Limited | An improved process for the preparation of pyrrole derivatives |
| US10385017B2 (en) | 2015-10-14 | 2019-08-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
| KR101913830B1 (ko) * | 2016-12-05 | 2018-10-31 | 주식회사 코쿤디자인 | 기능성 led 어셈블리를 이용한 디스플레이 장치 |
| EP3551180B1 (en) | 2016-12-09 | 2021-09-29 | Cadila Healthcare Limited | Treatment for primary biliary cholangitis |
| EP3923932A4 (en) * | 2019-02-13 | 2022-11-16 | Cadila Healthcare Limited | Treatment for polycystic ovarian syndrome (pcos) |
| US20220169603A1 (en) * | 2019-03-11 | 2022-06-02 | Cadila Healthcare Ltd. | Novel salts, crystalline forms and premix of hypolipidemic agent |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
| US5354772A (en) | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
| US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
| FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| EP0648212B1 (en) | 1992-07-03 | 2001-10-24 | Smithkline Beecham Plc | Benzoxazole and benzothiazole derivatives as pharmaceutical |
| GB9225386D0 (en) | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
| US5387613A (en) | 1993-07-23 | 1995-02-07 | Ribogene, Inc. | Treatment of tachyarrhythmias of supraventricular origin |
| GB9326171D0 (en) | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
| WO1996004261A1 (en) | 1994-07-29 | 1996-02-15 | Smithkline Beecham Plc | Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes |
| KR100380875B1 (ko) | 1995-04-28 | 2003-10-10 | 다이이찌 세이야꾸 가부시기가이샤 | 펜타사이클릭화합물 |
| GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9606805D0 (en) | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
| WO1999019313A1 (en) | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| US6130214A (en) | 1997-10-27 | 2000-10-10 | Dr. Reddy's Research Foundation | Benzothiazin and benzoxazin derivatives; their preparation and uses |
| WO1999008501A2 (en) | 1998-04-23 | 1999-02-25 | Dr. Reddy's Research Foundation | New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| EP1082313A1 (en) | 1998-05-27 | 2001-03-14 | Dr. Reddy's Research Foundation | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| AU6325599A (en) | 1998-10-21 | 2000-05-08 | Dr. Reddy's Research Foundation | New compounds, their preparation and use |
| JP2002527503A (ja) | 1998-10-21 | 2002-08-27 | ノボ ノルディスク アクティーゼルスカブ | 新規化合物類、それらの調製及び使用 |
| AU6325799A (en) | 1998-10-21 | 2000-05-08 | Dr. Reddy's Research Foundation | New compounds, their preparation and use |
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| EA007959B1 (ru) | 2000-01-19 | 2007-02-27 | Кадила Хелзкэр Лтд. | Новые соединения, обладающие гиполипидемической, гипохолестеринемической активностью, способ их получения и содержащие их композиции |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| WO2002024625A2 (en) | 2000-09-22 | 2002-03-28 | Dr. Reddy's Research Foundation | Process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| US6987123B2 (en) | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| JP4745616B2 (ja) * | 2003-02-26 | 2011-08-10 | 武田薬品工業株式会社 | 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾール誘導体の安定化方法 |
| JP4261546B2 (ja) | 2003-09-26 | 2009-04-30 | 三菱レイヨン株式会社 | 電気泳動装置および電気泳動法 |
| EA013427B1 (ru) | 2004-03-15 | 2010-04-30 | Такеда Фармасьютикал Компани Лимитед | Ингибиторы дипептидилпептидазы |
| KR101250632B1 (ko) * | 2006-02-22 | 2013-04-03 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 안정화 의약 조성물 |
| EP2018157A2 (en) | 2006-04-26 | 2009-01-28 | Astron Research Limited | Controlled release formulation comprising anti-epileptic drugs |
| JP5424571B2 (ja) * | 2007-04-12 | 2014-02-26 | 協和発酵キリン株式会社 | トピラマート含有固形製剤 |
| AU2010323066B2 (en) | 2009-11-26 | 2014-12-11 | Genfit | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
| AU2011316565A1 (en) * | 2010-10-12 | 2013-05-02 | Cerecor Inc. | Antitussive compositions comprising memantine |
| PL2670486T3 (pl) | 2011-01-31 | 2016-08-31 | Cadila Healthcare Ltd | Leczenie lipodystrofii |
| GEP201706663B (en) * | 2013-04-22 | 2017-05-10 | Cadila Healthcare Ltd | Novel composition for nonalcoholic fatty liver disease (nafld |
| EP3004053B1 (en) | 2013-05-30 | 2021-03-24 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201636015A (zh) | 2013-07-05 | 2016-10-16 | 卡地拉保健有限公司 | 協同性組成物 |
| IN2013MU02470A (enExample) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| US9951009B2 (en) | 2013-08-29 | 2018-04-24 | Cadila Healthcare Limited | Polymorphic form of pyrrole derivative and intermediate thereof |
| WO2015033357A2 (en) | 2013-09-06 | 2015-03-12 | Cadila Healthcare Limited | An improved process for the preparation of pyrrole derivatives |
-
2013
- 2013-07-25 IN IN2470MU2013 patent/IN2013MU02470A/en unknown
-
2014
- 2014-07-24 CA CA2917923A patent/CA2917923A1/en not_active Abandoned
- 2014-07-24 NZ NZ714558A patent/NZ714558A/en not_active IP Right Cessation
- 2014-07-24 JP JP2016522969A patent/JP2016523895A/ja active Pending
- 2014-07-24 MA MA38865A patent/MA38865A1/fr unknown
- 2014-07-24 BR BR112015031878A patent/BR112015031878A2/pt not_active IP Right Cessation
- 2014-07-24 KR KR1020157036380A patent/KR101786843B1/ko not_active Expired - Fee Related
- 2014-07-24 US US14/899,912 patent/US9610277B2/en active Active
- 2014-07-24 EP EP14787059.6A patent/EP3024446A1/en not_active Withdrawn
- 2014-07-24 EA EA201690072A patent/EA201690072A1/ru unknown
- 2014-07-24 MX MX2015016971A patent/MX374628B/es active IP Right Grant
- 2014-07-24 AU AU2014294548A patent/AU2014294548B2/en not_active Expired - Fee Related
- 2014-07-24 WO PCT/IN2014/000489 patent/WO2015011730A1/en not_active Ceased
- 2014-07-24 CN CN201480041453.7A patent/CN105407873A/zh active Pending
- 2014-07-24 SG SG11201509798PA patent/SG11201509798PA/en unknown
- 2014-07-24 HK HK16107193.2A patent/HK1219222A1/zh unknown
- 2014-07-24 TW TW103125304A patent/TW201545773A/zh unknown
- 2014-07-25 AR ARP140102777A patent/AR097067A1/es unknown
-
2015
- 2015-07-24 AP AP2015008876A patent/AP2015008876A0/xx unknown
- 2015-11-25 ZA ZA2015/08682A patent/ZA201508682B/en unknown
- 2015-12-17 PH PH12015502802A patent/PH12015502802A1/en unknown
-
2017
- 2017-03-31 US US15/475,812 patent/US10098868B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201509798PA (en) | 2016-02-26 |
| IN2013MU02470A (enExample) | 2015-06-26 |
| KR101786843B1 (ko) | 2017-10-18 |
| MX374628B (es) | 2025-03-06 |
| MA38865A1 (fr) | 2017-12-29 |
| EP3024446A1 (en) | 2016-06-01 |
| AU2014294548B2 (en) | 2017-08-10 |
| KR20160013150A (ko) | 2016-02-03 |
| AU2014294548A1 (en) | 2015-12-17 |
| MX2015016971A (es) | 2016-04-25 |
| PH12015502802A1 (en) | 2016-03-14 |
| CA2917923A1 (en) | 2015-01-29 |
| AP2015008876A0 (en) | 2015-11-30 |
| HK1219222A1 (zh) | 2017-03-31 |
| WO2015011730A1 (en) | 2015-01-29 |
| US20160136131A1 (en) | 2016-05-19 |
| AR097067A1 (es) | 2016-02-17 |
| ZA201508682B (en) | 2017-03-29 |
| CN105407873A (zh) | 2016-03-16 |
| TW201545773A (zh) | 2015-12-16 |
| JP2016523895A (ja) | 2016-08-12 |
| EA201690072A1 (ru) | 2016-06-30 |
| US9610277B2 (en) | 2017-04-04 |
| US20170266158A1 (en) | 2017-09-21 |
| US10098868B2 (en) | 2018-10-16 |
| NZ714558A (en) | 2017-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015031878A2 (pt) | composição farmacêutica | |
| BR112015022972A2 (pt) | composição farmacêutica de cloridrato de s-cetamina | |
| EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| BR112015021983A8 (pt) | compostos heterocíclicos, composições e usos dos mesmos | |
| BR112014009391A2 (pt) | dosagem faseada de clopidogrel | |
| CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
| BR112015010908A2 (pt) | derivado de pirrol sulfonamida, método de preparação para o mesmo e aplicação médica do mesmo | |
| BR112015018738A8 (pt) | compostos de tetra-hidropirrolotiazina, seus usos, e composição farmacêutica | |
| BR112016006651B8 (pt) | compostos derivados de quinolizina substituídos, composição farmacêutica que os compreende e uso dos referidos compostos | |
| EA201690247A1 (ru) | Аминометилбиарильные производные-ингибиторы фактора d комплемента и их применения | |
| MX389600B (es) | Nueva composición terapéutica que contiene ingrediente activo de apomorfinas. | |
| NZ607580A (en) | N-heteroaryl compounds | |
| MX394588B (es) | Composición farmacéutica. | |
| BR112013017302A2 (pt) | formulações de imunossupressor | |
| NZ720328A (en) | Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease | |
| EA201600434A1 (ru) | Применение производных бензимидазолпролина | |
| BR112015026967A8 (pt) | fenoxietil di-hidro-1h-isoquinolina, seus usos, e composição farmacêutica | |
| BR112018010107A2 (pt) | composição farmacêutica para o tratamento ou prevenção de nash | |
| PE20151607A1 (es) | Formulaciones de compuestos organicos | |
| BR112015004523A2 (pt) | compostos de tetraciclina | |
| PH12016500577B1 (en) | Piperazine derivatives and the use thereof as medicament | |
| BR112016011778A2 (pt) | Pirazol fluorofenila, seus usos, e composição farmacêutica | |
| JOP20170197B1 (ar) | الصيغة الجديدة التي تشتمل على مشتق بنزيميدازول | |
| BR112015006243A2 (pt) | agentes antibacterianos de fenicol | |
| BR112015019307A8 (pt) | derivados de ácido butanóico substituído com bisfenila, seus usos, e composição farmacêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2524 DE 21-05-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |